Citations (79)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (16)
Pierre Dillard, Nicholas Casey, Sylvie Pollmann, Patrik Vernhoff, Gustav Gaudernack, Gunnar Kvalheim, Sébastien Wälchli & Else Marit Inderberg. (2021) Targeting KRAS mutations with HLA class II-restricted TCRs for the treatment of solid tumors. OncoImmunology 10:1.
Read now
Read now
Jon Amund Kyte, Anne Fåne, Martin Pule & Gustav Gaudernack. (2019) Transient redirection of T cells for adoptive cell therapy with telomerase-specific T helper cell receptors isolated from long term survivors after cancer vaccination. OncoImmunology 8:4.
Read now
Read now
Miki Tsuruta, Shohei Ueda, Poh Yin Yew, Isao Fukuda, Sachiko Yoshimura, Hiroyuki Kishi, Hiroshi Hamana, Masatoshi Hirayama, Junji Yatsuda, Atsushi Irie, Satoru Senju, Eiji Yuba, Tomomi Kamba, Masatoshi Eto, Hideki Nakayama & Yasuharu Nishimura. (2018) Bladder cancer-associated cancer-testis antigen-derived long peptides encompassing both CTL and promiscuous HLA class II-restricted Th cell epitopes induced CD4+ T cells expressing converged T-cell receptor genes in vitro. OncoImmunology 7:4.
Read now
Read now
John C. Henegan & Guru Sonpavde. (2018) Promising immunotherapy for prostate cancer. Expert Opinion on Biological Therapy 18:2, pages 109-120.
Read now
Read now
Yung Ki Lee, Beta Subakti Nata’atmaja, Byung Hwi Kim, Chang Sik Pak & Chan Yeong Heo. (2017) Protective effect of telomerase-based 16-mer peptide vaccine (GV1001) on inferior epigastric island skin flap survivability in ischaemia-reperfusion injury rat model. Journal of Plastic Surgery and Hand Surgery 51:3, pages 210-216.
Read now
Read now
Jon Amund Kyte, Gustav Gaudernack, Anne Faane, Kari Lislerud, Else Marit Inderberg, Paal Brunsvig, Steinar Aamdal, Gunnar Kvalheim, Sébastien Wälchli & Martin Pule. (2016) T-helper cell receptors from long-term survivors after telomerase cancer vaccination for use in adoptive cell therapy. OncoImmunology 5:12.
Read now
Read now
Jon Amund Kyte, Steinar Aamdal, Svein Dueland, Stein Sæbøe-Larsen, Else Marit Inderberg, Ulf Erik Madsbu, Eva Skovlund, Gustav Gaudernack & Gunnar Kvalheim. (2016) Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells. OncoImmunology 5:11.
Read now
Read now
Eleftheria A. Anastasopoulou, Ioannis F. Voutsas, Michael Papamichail, Constantin N. Baxevanis & Sonia A. Perez. (2016) MHC class II tetramer analyses in AE37-vaccinated prostate cancer patients reveal vaccine-specific polyfunctional and long-lasting CD4+ T-cells. OncoImmunology 5:7.
Read now
Read now
Masatoshi Hirayama, Yusuke Tomita, Akira Yuno, Hirotake Tsukamoto, Satoru Senju, Yuya Imamura, Mohammad Abu Sayem, Atsushi Irie, Yoshihiro Yoshitake, Daiki Fukuma, Masanori Shinohara, Akinobu Hamada, Hirofumi Jono, Eiji Yuba, Kenji Kono, Koji Yoshida, Takuya Tsunoda, Hideki Nakayama & Yasuharu Nishimura. (2016) An oncofetal antigen, IMP-3-derived long peptides induce immune responses of both helper T cells and CTLs. OncoImmunology 5:6.
Read now
Read now
Caroline Laheurte, Jeanne Galaine, Laurent Beziaud, Magalie Dosset, Jerome Kerzerho, Claire Jacquemard, Béatrice Gaugler, Christophe Ferrand, Anne Dormoy, François Aubin, Pascale Jacoulet, Virginie Westeel, Christophe Borg, Eric Tartour, Yann Godet, Bernard Maillère & Olivier Adotévi. (2016) Immunoprevalence and magnitude of HLA-DP4 versus HLA-DR-restricted spontaneous CD4+ Th1 responses against telomerase in cancer patients. OncoImmunology 5:5.
Read now
Read now
Jonathan Pol, Norma Bloy, Aitziber Buqué, Alexander Eggermont, Isabelle Cremer, Catherine Sautès-Fridman, Jérôme Galon, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial Watch: Peptide-based anticancer vaccines. OncoImmunology 4:4.
Read now
Read now
Robert K Bright, Jennifer D Bright & Jennifer A Byrne. (2014) Overexpressed oncogenic tumor-self antigens. Human Vaccines & Immunotherapeutics 10:11, pages 3297-3305.
Read now
Read now
Annacarmen Petrizzo, Maria Tagliamonte, Marialina Tornesello, Franco M Buonaguro & Luigi Buonaguro. (2014) Systems vaccinology for cancer vaccine development. Expert Review of Vaccines 13:6, pages 711-719.
Read now
Read now
Daniela Fenoglio, Paolo Traverso, Alessia Parodi, Francesca Kalli, Maurizio Zanetti & Gilberto Filaci. (2013) Generation of more effective cancer vaccines. Human Vaccines & Immunotherapeutics 9:12, pages 2543-2547.
Read now
Read now
Fernando Aranda, Erika Vacchelli, Alexander Eggermont, Jérôme Galon, Catherine Sautès-Fridman, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2013) Trial Watch. OncoImmunology 2:12.
Read now
Read now
Erika Vacchelli, Ilio Vitale, Eric Tartour, Alexander Eggermont, Catherine Sautès-Fridman, Jérôme Galon, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2013) Trial Watch. OncoImmunology 2:9.
Read now
Read now
Articles from other publishers (63)
Eman I.K. Ibrahim, Espen B. Ellingsen, Sara M. Mangsbo & Lena E. Friberg. (2024) Bridging responses to a human telomerase reverse transcriptase-based peptide cancer vaccine candidate in a mechanism-based model. International Immunopharmacology 126, pages 111225.
Crossref
Crossref
Jung Hyun Jo, Yong-Tae Kim, Ho Soon Choi, Ho Gak Kim, Hong Sik Lee, Young Woo Choi, Dong Uk Kim, Kwang Hyuck Lee, Eui Joo Kim, Joung-Ho Han, Seung Ok Lee, Chang-Hwan Park, Eun Kwang Choi, Jae Woo Kim, Jae Yong Cho, Woo Jin Lee, Hyungsik Roger Moon, Mi-Suk Park, Sangjae Kim & Si Young Song. (2023) Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum eotaxin levels (KG4/2015): an open-label, randomised, Phase 3 trial. British Journal of Cancer.
Crossref
Crossref
Fatemeh Zahedipour, Khadijeh Jamialahmadi, Parvin Zamani & Mahmoud Reza Jaafari. (2023) Improving the efficacy of peptide vaccines in cancer immunotherapy. International Immunopharmacology 123, pages 110721.
Crossref
Crossref
Espen B. Ellingsen, Steven O'Day, Artur Mezheyeuski, Agnieszka Gromadka, Trevor Clancy, Timothy S. Kristedja, Mohammed Milhem & Yousef Zakharia. (2023) Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I Trial. Clinical Cancer Research 29:16, pages 3026-3036.
Crossref
Crossref
Ali Khezrian, Mazaher Ahmadi, Pooneh Mokarram, Saeid Afshar & Yasin Parvizi. (2023) A Review of Recent Advances in Peptide-Based Anticancer Therapeutic Vaccines and Nanovaccines in Prostate Cancer. International Journal of Peptide Research and Therapeutics 29:5.
Crossref
Crossref
Espen Basmo Ellingsen, Jens Bjørheim & Gustav Gaudernack. (2023) Therapeutic cancer vaccination against telomerase: clinical developments in melanoma. Current Opinion in Oncology 35:2, pages 100-106.
Crossref
Crossref
Olivier Adotévi, Dewi Vernerey, Pascale Jacoulet, Aurélia Meurisse, Caroline Laheurte, Hamadi Almotlak, Marion Jacquin, Vincent Kaulek, Laura Boullerot, Marine Malfroy, Emeline Orillard, Guillaume Eberst, Aurélie Lagrange, Laure Favier, Marie Gainet-Brun, Ludovic Doucet, Luis Teixeira, Zineb Ghrieb, Anne-Laure Clairet, Yves Guillaume, Marie Kroemer, Didier Hocquet, Mélanie Moltenis, Samuel Limat, Elisabeth Quoix, Céline Mascaux, Didier Debieuvre, Christine Fagnoni-Legat, Christophe Borg & Virginie Westeel. (2023) Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide–Based Vaccine in Patients With Refractory Advanced Non–Small-Cell Lung Cancer: A Phase Ib/Phase IIa De-Escalation Study. Journal of Clinical Oncology 41:2, pages 373-384.
Crossref
Crossref
Reena Thakur, Chander Raman Suri, Indu Pal Kaur & Praveen Rishi. (2023) Peptides as Diagnostic, Therapeutic, and Theranostic Tools: Progress and Future Challenges. Critical Reviews™ in Therapeutic Drug Carrier Systems 40:1, pages 49-100.
Crossref
Crossref
Jae Hyeon Kim, Young-Rak Cho, Eun-Kyung Ahn, Sunho Kim, Surim Han, Sung Joon Kim, Gyu-Un Bae, Joa Sub Oh & Dong-Wan Seo. (2022) A novel telomerase-derived peptide GV1001-mediated inhibition of angiogenesis: Regulation of VEGF/VEGFR-2 signaling pathways. Translational Oncology 26, pages 101546.
Crossref
Crossref
Sólrún Melkorka Maggadóttir, Gunnar Kvalheim, Patrik Wernhoff, Stein Sæbøe-Larssen, Mona-Elisabeth Revheim, Dag Josefsen, Sébastien Wälchli, Åslaug Helland & Else Marit Inderberg. (2022) A phase I/II escalation trial design T-RAD: Treatment of metastatic lung cancer with mRNA-engineered T cells expressing a T cell receptor targeting human telomerase reverse transcriptase (hTERT). Frontiers in Oncology 12.
Crossref
Crossref
Jixuan Gao & Hilda A. Pickett. (2022) Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies. Nature Reviews Cancer 22:9, pages 515-532.
Crossref
Crossref
Espen Basmo Ellingsen, Elin Aamdal, Tormod Guren, Wolfgang Lilleby, Paal F Brunsvig, Sara M Mangsbo, Steinar Aamdal, Eivind Hovig, Nadia Mensali, Gustav Gaudernack & Else Marit Inderberg. (2022) Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials. Journal for ImmunoTherapy of Cancer 10:5, pages e004345.
Crossref
Crossref
Mara Cenerenti, Margaux Saillard, Pedro Romero & Camilla Jandus. (2022) The Era of Cytotoxic CD4 T Cells. Frontiers in Immunology 13.
Crossref
Crossref
Timothy Samec, Jessica Boulos, Serena Gilmore, Anthony Hazelton & Angela Alexander-Bryant. (2022) Peptide-based delivery of therapeutics in cancer treatment. Materials Today Bio 14, pages 100248.
Crossref
Crossref
Hueng-Chuen Fan, Fung-Wei Chang, Jeng-Dau Tsai, Kao-Min Lin, Chuan-Mu Chen, Shinn-Zong Lin, Ching-Ann Liu & Horng-Jyh Harn. (2021) Telomeres and Cancer. Life 11:12, pages 1405.
Crossref
Crossref
Kjersti Flatmark, Annette Torgunrud, Karianne G Fleten, Ben Davidson, Hedvig V Juul, Nadia Mensali, Christin Lund-Andersen & Else Marit Inderberg. (2021)
Peptide vaccine targeting mutated
GNAS
: a potential novel treatment for pseudomyxoma peritonei
. Journal for ImmunoTherapy of Cancer 9:10, pages e003109.
Crossref
Crossref
Espen Basmo Ellingsen, Sara M. Mangsbo, Eivind Hovig & Gustav Gaudernack. (2021) Telomerase as a Target for Therapeutic Cancer Vaccines and Considerations for Optimizing Their Clinical Potential. Frontiers in Immunology 12.
Crossref
Crossref
Elin Aamdal, Else Marit Inderberg, Espen Basmo Ellingsen, Wenche Rasch, Paal Fredrik Brunsvig, Steinar Aamdal, Karen-Marie Heintz, Daniel Vodák, Sigve Nakken, Eivind Hovig, Marta Nyakas, Tormod Kyrre Guren & Gustav Gaudernack. (2021) Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma - Five-Year Follow Up of a Phase I/IIa Trial. Frontiers in Immunology 12.
Crossref
Crossref
Pierre Dillard, Hakan Köksal, Solrun Melkorka Maggadottir, Anna Winge-Main, Sylvie Pollmann, Mathilde Menard, Marit Renée Myhre, Gunhild M. Mælandsmo, Vivi Ann Flørenes, Gustav Gaudernack, Gunnar Kvalheim, Sébastien Wälchli & Else Marit Inderberg. (2021) Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy. Molecular Therapy 29:3, pages 1199-1213.
Crossref
Crossref
Vania Lo Presti, Frank Buitenwerf, Niek P. van Til & Stefan Nierkens. (2020) Gene Augmentation and Editing to Improve TCR Engineered T Cell Therapy against Solid Tumors. Vaccines 8:4, pages 733.
Crossref
Crossref
Paal F. Brunsvig, Tormod Kyrre Guren, Marta Nyakas, Claudius H. Steinfeldt-Reisse, Wenche Rasch, Jon Amund Kyte, Hedvig Vidarsdotter Juul, Steinar Aamdal, Gustav Gaudernack & Else Marit Inderberg. (2020) Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer. Frontiers in Immunology 11.
Crossref
Crossref
Peter Brossart. (2020) The Role of Antigen Spreading in the Efficacy of Immunotherapies. Clinical Cancer Research 26:17, pages 4442-4447.
Crossref
Crossref
Simone Negrini, Raffaele De Palma & Gilberto Filaci. (2020) Anti-Cancer Immunotherapies Targeting Telomerase. Cancers 12:8, pages 2260.
Crossref
Crossref
Stina George Fernandes, Rebecca Dsouza, Gouri Pandya, Anuradha Kirtonia, Vinay Tergaonkar, Sook Y. Lee, Manoj Garg & Ekta Khattar. (2020) Role of Telomeres and Telomeric Proteins in Human Malignancies and Their Therapeutic Potential. Cancers 12:7, pages 1901.
Crossref
Crossref
Else Marit Inderberg & Sébastien Wälchli. (2020) Long-term surviving cancer patients as a source of therapeutic TCR. Cancer Immunology, Immunotherapy 69:5, pages 859-865.
Crossref
Crossref
Joseph Berei, Adam Eckburg, Edward Miliavski, Austin D. Anderson, Rachel J. Miller, Joshua Dein, Allison M. Giuffre, Diana Tang, Shreya Deb, Kavya Sri Racherla, Meet Patel, Monica Saravana Vela & Neelu Puri. (2020) Potential Telomere-Related Pharmacological Targets. Current Topics in Medicinal Chemistry 20:6, pages 458-484.
Crossref
Crossref
Nicola Relitti, Akella P. Saraswati, Stefano Federico, Tuhina Khan, Margherita Brindisi, Daniela Zisterer, Simone Brogi, Sandra Gemma, Stefania Butini & Giuseppe Campiani. (2020) Telomerase-based Cancer Therapeutics: A Review on their Clinical Trials. Current Topics in Medicinal Chemistry 20:6, pages 433-457.
Crossref
Crossref
Xuelu DingXuewen LiuFeng WangFei WangXin Geng. (2020) Role of Senescence and Neuroprotective Effects of Telomerase in Neurodegenerative Diseases. Rejuvenation Research 23:2, pages 150-158.
Crossref
Crossref
Luis Teixeira, Jacques Medioni, Julie Garibal, Olivier Adotevi, Ludovic Doucet, Marie-Agnès Dragon Durey, Zineb Ghrieb, Jean-Jacques Kiladjian, Mara Brizard, Caroline Laheurte, Maria Wehbe, Elodie Pliquet, Marie Escande, Rémy Defrance, Stephane Culine, Stephane Oudard, Simon Wain-Hobson, Valérie Doppler, Thierry Huet & Pierre Langlade-Demoyen. (2020) A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors. Clinical Cancer Research 26:3, pages 588-597.
Crossref
Crossref
Carla Costa-Nunes, Amélie Cachot, Sara Bobisse, Marion Arnaud, Raphael Genolet, Petra Baumgaertner, Daniel E. Speiser, Pedro M. Sousa Alves, Federico Sandoval, Olivier Adotévi, Walter Reith, Maria Pia Protti, George Coukos, Alexandre Harari, Pedro Romero & Camilla Jandus. (2019) High-throughput Screening of Human Tumor Antigen–specific CD4 T Cells, Including Neoantigen-reactive T Cells. Clinical Cancer Research 25:14, pages 4320-4331.
Crossref
Crossref
Yu-Hsuan Lee, Yu-Ying Chen, Ya-Ling Yeh, Ying-Jan Wang & Rong-Jane Chen. (2019) Stilbene Compounds Inhibit Tumor Growth by the Induction of Cellular Senescence and the Inhibition of Telomerase Activity. International Journal of Molecular Sciences 20:11, pages 2716.
Crossref
Crossref
Eishiro Mizukoshi & Shuichi Kaneko. (2019) Telomerase-Targeted Cancer Immunotherapy. International Journal of Molecular Sciences 20:8, pages 1823.
Crossref
Crossref
Tyler R. McCaw, Mei Li, Dmytro Starenki, Sara J. Cooper, Mingyong Liu, Selene Meza-Perez, Rebecca C. Arend, Donald J. Buchsbaum, Andres Forero & Troy D. Randall. (2018) The expression of MHC class II molecules on murine breast tumors delays T-cell exhaustion, expands the T-cell repertoire, and slows tumor growth. Cancer Immunology, Immunotherapy 68:2, pages 175-188.
Crossref
Crossref
Sjoerd H. van der Burg. (2018) Correlates of immune and clinical activity of novel cancer vaccines. Seminars in Immunology 39, pages 119-136.
Crossref
Crossref
Chuan Wang, James Dickie, Ruhcha V. Sutavani, Catherine Pointer, Gareth J. Thomas & Natalia Savelyeva. (2018) Targeting Head and Neck Cancer by Vaccination. Frontiers in Immunology 9.
Crossref
Crossref
Caroline Tosch, Bérangère Bastien, Luc Barraud, Benoit Grellier, Virginie Nourtier, Murielle Gantzer, Jean Marc Limacher, Eric Quemeneur, Kaïdre Bendjama & Xavier Préville. (2017) Viral based vaccine TG4010 induces broadening of specific immune response and improves outcome in advanced NSCLC. Journal for ImmunoTherapy of Cancer 5:1.
Crossref
Crossref
Chahal Kailashiya, Hanjabam Barun Sharma & Jyotsna Kailashiya. (2017) Telomerase based anticancer immunotherapy and vaccines approaches. Vaccine 35:43, pages 5768-5775.
Crossref
Crossref
Wolfgang Lilleby, Gustav Gaudernack, Paal F. Brunsvig, Ljiljana Vlatkovic, Melanie Schulz, Kate Mills, Knut H?kon Hole & Else Marit Inderberg. (2017) Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancer. Cancer Immunology, Immunotherapy 66:7, pages 891-901.
Crossref
Crossref
Ji-Eun Chang, Hyun Jun Kim, Sanghoon Jheon & Cheong Lim. (2017) Protective effects of GV1001 on myocardial ischemia-reperfusion injury. Molecular Medicine Reports 16:5, pages 7315-7320.
Crossref
Crossref
In Ah Choi, Ji Yong Choi, Sundo Jung, Fathihah Basri, Seho Park & Eun Young Lee. (2017) GV1001 immunotherapy ameliorates joint inflammation in a murine model of rheumatoid arthritis by modifying collagen-specific T-cell responses and downregulating antigen-presenting cells. International Immunopharmacology 46, pages 186-193.
Crossref
Crossref
Fangjun Chen & Fanyan Meng. 2017. Personalized Management of Gastric Cancer. Personalized Management of Gastric Cancer
131
147
.
Hong Kim, Eun-Hye Seo, Seung-Hyun Lee & Bum-Joon Kim. (2016) The Telomerase-Derived Anticancer Peptide Vaccine GV1001 as an Extracellular Heat Shock Protein-Mediated Cell-Penetrating Peptide. International Journal of Molecular Sciences 17:12, pages 2054.
Crossref
Crossref
Jeanne Galaine, Guillaume Kellermann, Yves Guillaume, Romain Boidot, Emilie Picard, Romain Loyon, Lise Queiroz, Laura Boullerot, Laurent Beziaud, Marine Jary, Laura Mansi, Claire André, Lydie Lethier, Evelyne Ségal-Bendirdjian, Christophe Borg, Yann Godet & Olivier Adotévi. (2016) Heparan Sulfate Proteoglycans Promote Telomerase Internalization and MHC Class II Presentation on Dendritic Cells. The Journal of Immunology 197:5, pages 1597-1608.
Crossref
Crossref
Jon Bjoern, Trine Zeeberg Iversen, Nikolaj Juul Nitschke, Mads Hald Andersen & Inge Marie Svane. (2016) Safety, immune and clinical responses in metastatic melanoma patients vaccinated with a long peptide derived from indoleamine 2,3-dioxygenase in combination with ipilimumab. Cytotherapy 18:8, pages 1043-1055.
Crossref
Crossref
Hyun-Hee Park, Hyun-Jung Yu, Sangjae Kim, Gabseok Kim, Na-Young Choi, Eun-Hye Lee, Young Joo Lee, Moon-Young Yoon, Kyu-Yong Lee & Seong-Ho Koh. (2016) Neural stem cells injured by oxidative stress can be rejuvenated by GV1001, a novel peptide, through scavenging free radicals and enhancing survival signals. NeuroToxicology 55, pages 131-141.
Crossref
Crossref
Yucheng Xu & Amir Goldkorn. (2016) Telomere and Telomerase Therapeutics in Cancer. Genes 7:6, pages 22.
Crossref
Crossref
Seoung-Ae Lee, Jinhee Kim, Jihyun Sim, Sang-Gyune Kim, Yoon-Hoh Kook, Chung-Gyu Park, Hang-Rae Kim & Bum-Joon Kim. (2016) A telomerase-derived peptide regulates reactive oxygen species and hepatitis C virus RNA replication in HCV-infected cells via heat shock protein 90. Biochemical and Biophysical Research Communications 471:1, pages 156-162.
Crossref
Crossref
Vani Lakshminarayanan, Nitin T. Supekar, Jie Wei, Dustin B. McCurry, Amylou C. Dueck, Heidi E. Kosiorek, Priyanka P. Trivedi, Judy M. Bradley, Cathy S. Madsen, Latha B. Pathangey, Dominique B. Hoelzinger, Margreet A. Wolfert, Geert-Jan Boons, Peter A. Cohen & Sandra J. Gendler. (2016) MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice. PLOS ONE 11:1, pages e0145920.
Crossref
Crossref
Gaute Lund Hansen, Gustav Gaudernack, Paal Fredrik Brunsvig, Milada Cvancarova & Jon Amund Kyte. (2015) Immunological factors influencing clinical outcome in lung cancer patients after telomerase peptide vaccination. Cancer Immunology, Immunotherapy 64:12, pages 1609-1621.
Crossref
Crossref
Nana H. Overgaard, Thomas M. Frøsig, Simon Welner, Michael Rasmussen, Mette Ilsøe, Maria R. Sørensen, Mads H. Andersen, Søren Buus & Gregers Jungersen. (2015) Establishing the pig as a large animal model for vaccine development against human cancer. Frontiers in Genetics 6.
Crossref
Crossref
Mayumi Nakagawa, William Greenfield, Andrea Moerman-Herzog & Hannah N. Coleman. (2015)
Cross-Reactivity, Epitope Spreading, and
De Novo
Immune Stimulation Are Possible Mechanisms of Cross-Protection of Nonvaccine Human Papillomavirus (HPV) Types in Recipients of HPV Therapeutic Vaccines
. Clinical and Vaccine Immunology 22:7, pages 679-687.
Crossref
Crossref
Omer Araz, Elif Yilmazel Ucar, Mehmet Meral, Aslıhan Yalcin, Hamit Acemoglu, Hasan Dogan, Adem Karaman, Yener Aydin, Metin Gorguner & Metin Akgun. (2015) Frequency of Class I and II HLA alleles in patients with lung cancer according to chemotherapy response and 5-year survival. The Clinical Respiratory Journal 9:3, pages 297-304.
Crossref
Crossref
Jeanne Galaine, Christophe Borg, Yann Godet & Olivier Adotévi. (2015) Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer Vaccine. Vaccines 3:3, pages 490-502.
Crossref
Crossref
Maurizio Zanetti. (2015) Tapping CD4 T Cells for Cancer Immunotherapy: The Choice of Personalized Genomics. The Journal of Immunology 194:5, pages 2049-2056.
Crossref
Crossref
Gary Middleton, Paul Silcocks, Trevor Cox, Juan Valle, Jonathan Wadsley, David Propper, Fareeda Coxon, Paul Ross, Srinivasan Madhusudan, Tom Roques, David Cunningham, Stephen Falk, Nick Wadd, Mark Harrison, Pippa Corrie, Tim Iveson, Angus Robinson, Karen McAdam, Martin Eatock, Jeff Evans, Caroline Archer, Tamas Hickish, Angel Garcia-Alonso, Marianne Nicolson, William Steward, Alan Anthoney, William Greenhalf, Victoria Shaw, Eithne Costello, Dean Naisbitt, Charlotte Rawcliffe, Gemma Nanson & John Neoptolemos. (2014) Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial. The Lancet Oncology 15:8, pages 829-840.
Crossref
Crossref
Hyun-Hee Park, Kyu-Yong Lee, Sangjae Kim, Jessica Woojin Lee, Na-Young Choi, Eun-Hye Lee, Young Joo Lee, Sang-Hun Lee & Seong-Ho Koh. (2014) The novel vaccine peptide GV1001 effectively blocks β-amyloid toxicity by mimicking the extra-telomeric functions of human telomerase reverse transcriptase. Neurobiology of Aging 35:6, pages 1255-1274.
Crossref
Crossref
T.Y. Koo, J.-J. Yan & J. Yang. (2014) Protective Effect of Peptide GV1001 Against Renal Ischemia-Reperfusion Injury in Mice. Transplantation Proceedings 46:4, pages 1117-1122.
Crossref
Crossref
Lucia Picariello. (2014) Telomerase activity: An attractive target for cancer therapeutics. World Journal of Pharmacology 3:4, pages 86.
Crossref
Crossref
Sonia Quaratino, Ulf Forssmann & Jens-Peter Marschner. 2017. Cancer Vaccines. Cancer Vaccines
1
31
.
Jian Yan, Panyupa Pankhong, Thomas H. Shin, Nyamekye Obeng-Adjei, Matthew P. Morrow, Jewell N. Walters, Amir S. Khan, Niranjan Y. Sardesai & David B. Weiner. (2013) Highly Optimized DNA Vaccine Targeting Human Telomerase Reverse Transcriptase Stimulates Potent Antitumor Immunity. Cancer Immunology Research 1:3, pages 179-189.
Crossref
Crossref
Kee Chung Low & Vinay Tergaonkar. (2013) Telomerase: central regulator of all of the hallmarks of cancer. Trends in Biochemical Sciences 38:9, pages 426-434.
Crossref
Crossref
Wenbo Wang, Lei Yang, Liu Hu, Fen Li, Li Ren, Haijun Yu, Yu Liu, Ling Xia, Han Lei, Zhengkai Liao, Fuxiang Zhou, Conghua Xie & Yunfeng Zhou. (2013) Inhibition of UBE2D3 Expression Attenuates Radiosensitivity of MCF-7 Human Breast Cancer Cells by Increasing hTERT Expression and Activity. PLoS ONE 8:5, pages e64660.
Crossref
Crossref
Paul V. Lehmann & Srividya Sundararaman. 2013. The Tumor Immunoenvironment. The Tumor Immunoenvironment
725
740
.